Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.075 USD | +7.40% |
|
+15.32% | +15.61% |
07-08 | Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug | MT |
07-01 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 198M | |
+26.45% | 46.56B | |
+45.38% | 41.67B | |
+0.73% | 41.16B | |
+31.15% | 32.4B | |
+22.33% | 28.18B | |
-6.35% | 28.1B | |
+49.32% | 14.52B | |
+48.46% | 13.74B | |
+3.67% | 12.17B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Cantor Fitzgerald Initiates Outlook Therapeutics at Overweight With $4 Price Target